Djulbegovic B, Loughran TP, Hornung CA, Kloecker G, Efthimiadis EN, Hadley TJ, Englert J, Hoskins M, Goldsmith GH: The Quality of Medical Evidence in Hematology-Oncology. Am J Med. 1999, 106 (2): 198-205. 10.1016/S0002-9343(98)00391-X.
Moher D, Jadad AR, Tugwell P: Assessing the quality of randomized controlled trials. Current issues and future directions. Int J Technol Assess Health Care. 1996, 12 (2): 195-208. 10.1017/S0266462300009570.
Altman DG: Better reporting of randomised controlled trials: the CONSORT statement. BMJ. 1996, 313 (7057): 570-1.
Ziogas DC, Zintzaras E: Analysis of the quality of reporting of randomized controlled trials in acute and chronic myeloid leukemia, and myelodysplastic syndromes as governed by the CONSORT statement. Ann Epidemiol. 2009, 19 (7): 494-500. 10.1016/j.annepidem.2009.03.018.
Papathanasiou AA, Zintzaras E: Assessing the Quality of Reporting of Observational Studies in Cancer. Ann Epidemiol. 2009
Pfeifer M, Snodgrass GL: The continued use of retracted invalid scientific literature. JAMA. 1990, 263 (10): 1420-1423. 10.1001/jama.263.10.1420.
Olkin I: Meta-analysis: reconciling the results of independent studies. Stat Med. 1995, 14 (5-7): 457-472. 10.1002/sim.4780140507.
Juni P, Altman DG, Egger M: Systematic reviews in health care: Assessing the quality of controlled clinical trials. BMJ. 2001, 323 (7303): 42-6. 10.1136/bmj.323.7303.42.
Schulz KF, Chalmers I, Grimes DA, Altman DG: Assessing the quality of randomization from reports of controlled trials published in obstetrics and gynecology journals. JAMA. 1994, 272 (2): 125-8. 10.1001/jama.272.2.125.
Wood L, Egger M, Gluud LL, Schulz KF, Jüni P, Altman DG, Gluud C, Martin RM, Wood AJ, Sterne JA: Empirical evidence of bias in treatment effect estimates in controlled trials with different interventions and outcomes: meta-epidemiological study. BMJ. 2008, 15;336 (7644): 601-5. 10.1136/bmj.39465.451748.AD.
Schulz KF, Chalmers I, Hayes RJ, Altman DG: Empirical evidence of bias: dimensions of methodological quality associated with estimates of treatment effects in controlled trials. JAMA. 1995, 273 (5): 408-412. 10.1001/jama.273.5.408.
Liberati A, Himel HN, Chalmers TC: A quality assessment of randomized control trials of primary treatment of breast cancer. J Clin Oncol. 1986, 4 (6): 942-951.
Moher D, Pham B, Jones A, Cook DJ, Jadad AR, Moher M, Tugwell P, Klassen TP: Does quality of reports of randomized trials affect estimates of intervention efficacy reported in meta-analyses?. Lancet. 1999, 352 (9128): 609-613. 10.1016/S0140-6736(98)01085-X.
Moher D, Jones A, Lepage L: Use of the CONSORT Statement and quality of reports of randomized Trials: a comparative before-and-after evaluation. JAMA. 2001, 285 (15): 1992-5. 10.1001/jama.285.15.1992.
Junker C, Egger M, Schneider M, Zellweger T, Antes G: The CONSORT statement. JAMA. 1996, 276 (23): 1876-7. 10.1001/jama.276.23.1876.
Plint A, Moher D, Morrison A, Schulz K, Altman DG, Hill C, Gaboury I: Does the CONSORT checklist improve the quality of reports of randomized controlled trials? A systematic review. MJA. 2006, 185 (5): 263-7.
Moher D, Schulz KF, Altman DG, for the CONSORT Group: The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomized trials. Ann Intern Med. 2001, 134 (8): 657-662.
Altman DG, Schulz KF, Moher D, Egger M, Davidoff F, Elbourne D, Gøtzsche PC, Lang T, CONSORT GROUP (Consolidated Standards of Reporting Trials): The revised CONSORT statement for reporting randomized trials: explanation and elaboration. Ann Intern Med. 2001, 134 (8): 663-94.
Rennie D: CONSORT revised -- improving the reporting of randomized trials. JAMA. 2001, 285 (15): 2006-7. 10.1001/jama.285.15.2006.
McNamee D, Horton R: Lies, damn lies, and reports of RCTs. Lancet. 1996, 348 (9027): 562-10.1016/S0140-6736(05)64795-2.
Rennie D: How to report randomized controlled trials: the CONSORT statement. JAMA. 1996, 276 (8): 649-10.1001/jama.276.8.649.
Diamanti-Kandarakis E, Koulie CR, Bergiele AT, Filandra FA, Tsianateli TC, Spina GG, Zapanti ED, Bartzis MI: A survey of the polycystic ovary syndrome in the Greek Island of Lesbos: a hormonal and metabolic profile. J Clin Endocrinol Metab. 1999, 84 (11): 4006-11. 10.1210/jc.84.11.4006.
The Rotterdam ESHRE/ASRM-Sponsored PCOS consensus workshop group: Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod. 2004, 19 (1): 41-7. 10.1093/humrep/deh098.
Colditz G, Miller JN, Mosteller F: How study design affects outcomes in comparisons of therapy. I: Medical Stat Med. 1989, 8 (4): 441-454. 10.1002/sim.4780080408.
Huwiler-Müntener K, Jüni P, Junker C, Egger M: Quality of reporting of randomized trials as a measure of methodologic quality. JAMA. 2002, 287 (21): 2801-4. 10.1001/jama.287.21.2801.
Landis JR, Koch GG: The measurement of observer agreement for categorical data. Biometrics. 1977, 33 (2): 159-74. 10.2307/2529310.
Egger M, Jüni P, Bartlett C, Holenstein F, Sterne J: How important are comprehensive literature searches and the assessment of trail quality in systematic reviews? Empirical study. Health Technol Assess. 2003, 7 (1): 1-76.
Egger M, Zellweger-Zähner T, Schneider M, Junker C, Lengeler C, Antes G: Language bias in randomised controlled trials published in English and German. Lancet. 1997, 350 (9074): 326-9. 10.1016/S0140-6736(97)02419-7.
Devereaux PJ, Choi PT, El-Dika S, Bhandari M, Montori VM, Schünemann HJ, Garg AX, Busse JW, Heels-Ansdell D, Ghali WA, Manns BJ, Guyatt GH: An observational study found that authors of randomized controlled trials frequently use concealment of randomization and blinding, despite the failure to report these methods. J Clin Epidemiol. 2004, 57 (12): 1232-6. 10.1016/j.jclinepi.2004.03.017.
Soares HP, Daniels S, Kumar A, Clarke M, Scott C, Swann S, Djulbegovic B, Radiation Therapy Oncology Group: Bad reporting does not mean bad methods for randomized trials: observational study of randomized controlled trials performed by the Radiation Therapy Oncology Group. BMJ. 2004, 328 (7430): 22-4. 10.1136/bmj.328.7430.22.
Olivo SA, Macedo LG, Gadotti IC, Fuentes J, Stanton T, Magee DJ: Scales to Assess the Quality of Randomized Controlled Trials: A Systematic Review. Phys Ther. 2008, 88: 156-175.
Lai R, Chu R, Fraumeni M, Thabane L: Quality of randomized controlled trials reporting in the primary treatment of brain tumors. J Clin Oncol. 2006, 24 (7): 1136-1144. 10.1200/JCO.2005.03.1179.
Dias S, McNamee R, Vail A: Evidence of improving quality of reporting of randomized controlled trials in subfertility. Hum Reprod. 2006, 21 (10): 2617-27. 10.1093/humrep/del236.
Begg C, Cho M, Eastwood S, Horton R, Moher D, Olkin I, Pitkin R, Rennie D, Schulz KF, Simel D, Stroup DF: Improving the quality of reporting of randomized controlled trials. The CONSORT statement. JAMA. 1996, 276 (8): 637-9. 10.1001/jama.276.8.637.
Mills E, Wu P, Gagnier J, Devereaux PJ: The quality of randomized trial reporting in leading medical journals since the revised CONSORT statement. Contemporary Clinical Trials. 2005, 26 (4): 480-7. 10.1016/j.cct.2005.02.008.